| Literature DB >> 35116012 |
Jean-Luc C Mougeot1, Micaela F Beckman1, Holden C Langdon1, Rajesh V Lalla2, Michael T Brennan1, Farah K Bahrani Mougeot1.
Abstract
OBJECTIVES: Human papillomavirus (HPV) is a known etiological factor of oropharyngeal head and neck cancer (HNC). HPV positivity and periodontal disease have been associated with higher HNC risk, suggesting a role for oral bacterial species. Our objective was to determine oral microbiome profiles in HNC patients (HPV-positive and HPV-negative) and in healthy controls (HC).Entities:
Keywords: HPV; Leptotrichia spp.; head and neck cancer; next generation sequencing; oral microbiome
Year: 2022 PMID: 35116012 PMCID: PMC8803733 DOI: 10.3389/fmicb.2021.794546
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
FIGURE 1Overall analytical strategy. α-Diversity was calculated for Grp-All HNC vs. HC (N = 30; N = 20) and HPV+ vs. HPV– (N = 16; N = 7) and for Grp-noAB HNC vs. HC (N = 19; N = 20) and HPV+ vs. HPV– (N = 12; N = 3). Sample sites consisted of different combinations of buccal (B), plaque (P), saliva (S), and tongue (T) samples. β-Diversity was calculated using PERMANOVA by two different analytical designs: (1) Analytical design with “Diagnosis” and “Sample site” as fixed factors and “Antibiotic” as the nested random factor. Comparisons were Grp-All HNC vs. HC and Grp-noAB HNC vs. HC. (2) Analytical design with “HPV status” and “Sample site” as fixed factors and “Antibiotic” as the nested random factor. Grp-All comparisons were as follows: HPV vs. HC (N = 23; N = 20), HPV+ vs. HC (N = 16; N = 20), HPV– vs. HC (N = 7; N = 20), and HPV+ vs. HPV– (N = 16; N = 7). Grp-noAB comparisons were as follows: HPV vs. HC (N = 15; N = 20), HPV+ vs. HC (N = 12; N = 20), HPV– vs. HC (N = 3; N = 20), and HPV+ vs. HPV– (N = 12; N = 3). Distinct species were determined using LEfSe and Mann–Whitney U-tests for Grp-All and Grp-noAB comparisons of HPV+ vs. HPV– for the sample site combination BPST. Significant LEfSe bacterial species for HPV+ group were investigated for their roles in periodontal disease using conventional methods (PubMed, Google Scholar, etc.). Significant LEfSe HPV+ species using the Mann–Whitney U-test were analyzed by using MedCalc ROC curve analysis. Multi-marker combinatorial analysis was completed using CombiROC online tool (http://combiroc.eu/) for the bacterial species identified with MedCalc log(RA + 1) ROC curve AUC of 0.75 or greater (n = 10 species). CombiROC utilized raw RA data and log(RA + 1) transformed data. Microbial Interaction Network Database (MIND) online tool was used to identify possible interactions between most significant bacterial species. Pythonv3.6.2 code was used to extract PubMed abstracts matching key words to determine positive and negative training sets and were validated manually. Using NCBI LitSuggest online tool (https://www.ncbi.nlm.nih.gov/research/litsuggest/), 203 PubMed articles were classified to identify articles involving HPV infection in the oral microbiome.
Patient demographics and clinical characteristics.
| HNC | HC | Combined | HNC HPV+ | HNC HPV− | Combined | |
|
| 30 (22/8) | 20 (5/15) | 50 (27/23) | 16 (12/4) | 7 (5/2) | 23 (17/6) |
|
| 11/19 | 0/20 | 11/39 | 4/12 | 4/3 | 8/15 |
|
| ||||||
| Base of tongue | 4 | 4 | 4 | 0 | 4 | |
| Nasopharynx | 2 | 2 | 1 | 1 | 2 | |
| Oral cavity | 1 | 1 | 0 | 1 | 1 | |
| Oropharynx | 1 | 1 | 1 | 0 | 1 | |
| Supraglottis | 1 | 1 | 0 | 1 | 1 | |
| Tongue | 1 | 1 | 0 | 1 | 1 | |
| Tonsil | 8 | 8 | 8 | 0 | 8 | |
| Unknown | 5 | 5 | 2 | 3 | 5 | |
|
| ||||||
| Median | 55 | 55 | 55 | 54 | 61 | 54 |
| Mean | 54 | 52.7 | 54 | 54 | 51 | 53 |
| Std Dev | 12.02 | 15.29 | 12.93 | 6.47 | 20.29 | 11.93 |
| Range | 23–75 | 24–84 | 23–84 | 40–68 | 23–75 | 23–75 |
|
| ||||||
| M: Caucasian/African American | 22/0 | 5/0 | 27/0 | 12/0 | 5/0 | 17/0 |
| F: Caucasian/African American | 7/1 | 13/2 | 20/3 | 3/1 | 2/0 | 5/1 |
|
| 2.28 (2.03–2.52) | 2.09 (1.78–2.40) | 2.26 (2.06–2.46) | |||
|
| 1.74 (1.42–2.07) | 1.64 (1.02–2.26) | 1.73 (1.46–2.01) | |||
|
| ||||||
| BPST | 120 | 80 | 200 | 64 | 28 | 92 |
| BST | 120 | 72 | 192 | 54 | 30 | 84 |
| PST | 105 | 69 | 174 | 54 | 21 | 75 |
| BPS | 93 | 63 | 156 |
PD, probing depth; CAL, clinical attachment loss; Std Dev, standard deviation. PD and CAL are shown as the average with 95% confidence intervals in parentheses. Mann–Whitney U-tests comparing whole mouth average PD and whole mouth average CAL separately for HPV+ vs. HPV– patient groups were not found to be significantly different (p > 0.05).
α-diversity comparisons: HNC vs. HC and HNC HPV+ vs. HPV–.
| Variable | Min | Max | Mean | Std Dev | |
|
| |||||
|
| |||||
| HNC | 42 | 247 | 131.65 | 39.738 |
|
| HC | 53 | 281 | 143.5 | 42.448 | |
|
| |||||
| HNC | 42 | 224 | 127.87 | 36.689 |
|
| HC | 72 | 281 | 145.96 | 41.343 | |
|
| |||||
| HNC | 45 | 247 | 138.28 | 42.348 | 0.378 |
| HC | 53 | 581 | 143.91 | 44.884 | |
|
| |||||
| HNC | 42 | 267 | 135.09 | 42.93 |
|
| HC | 53 | 223 | 146.37 | 38.401 | |
|
| |||||
|
| |||||
| HNC | 45 | 247 | 131.17 | 38.434 | 0.056 |
| HC | 53 | 281 | 143.5 | 42448 | |
|
| |||||
| HNC | 45 | 224 | 139.91 | 33.5 |
|
| HC | 72 | 281 | 145.96 | 41.343 | |
|
| |||||
| HNC | 45 | 247 | 139.55 | 41.855 | 0.54 |
| HC | 53 | 281 | 14.91 | 44.884 | |
|
| |||||
| HNC | 69 | 267 | 136.13 | 42.264 |
|
| HC | 53 | 223 | 146.38 | 38.401 | |
|
| |||||
|
| |||||
| Negative | 42 | 218 | 127.25 | 37.99 | 0.413 |
| Positive | 45 | 247 | 133.47 | 39.39 | |
|
| |||||
| Negative | 42 | 218 | 119.67 | 40.014 | 0.063 |
| Positive | 45 | 214 | 134.20 | 34.948 | |
|
| |||||
| Negative | 42 | 218 | 130.52 | 40.964 | 0.483 |
| Positive | 69 | 267 | 140.30 | 43.242 | |
|
| |||||
|
| |||||
| Negative | 86 | 177 | 128.83 | 28.197 | 0.919 |
| Positive | 45 | 247 | 130.17 | 40.511 | |
|
| |||||
| Negative | 86 | 174 | 128.08 | 28.273 | 0.787 |
| Positive | 45 | 214 | 130.71 | 34.437 | |
|
| |||||
| Negative | 86 | 177 | 133.67 | 30.332 | 0.921 |
| Positive | 69 | 267 | 137.29 | 45.687 | |
Significant values (p > 0.05) are shown in bold. Positive, HPV positive; Negative, HPV negative.
FIGURE 2PERMANOVA results comparisons flowchart. (A) Grp-All. (B) Grp-noAB. β-diversity analyses were performed using PERMANOVA in PRIMERv7 software (PRIMER-E Ltd., IvyBridge, United Kingdom) to compare microbial profiles of head and neck cancer (HNC) patients to healthy controls (HC) and to compare microbial profiles of HNC HPV-positive (HPV+) patients to HNC HPV– patients. Sample sites consisted of three to four site combinations of buccal (B), plaque (P), saliva (S), and tongue (T). PERMANOVA analysis was completed using two different analytical designs based on Bray–Curtis similarity matrices determined from square root transformed relative abundance data of 737 probes (620 species and 117 genus probes). Sample site combinations consisted of BPST, BST, and PST for (A) Grp-All HNC vs. HC (N = 30; N = 20) and (B) Grp-no Antibiotics (Grp-noAB) HNC vs. HC (N = 19; N = 20). For the Grp-All HNC vs. HC comparison, “Diagnosis” was the main fixed factor, and “Sample Site” was the secondary fixed factor. “Antibiotics” was nested into “Diagnosis” and “Sample site” factors as a random variable. Grp-noAB analytical design did not include antibiotics as a factor. For the analytical design considering HPV, “HPV status” and “Sample site” were set as fixed factors and “Antibiotics” as nested as random factor. Grp-noAB analytical design did not include antibiotics as a factor. Level of significance is denoted using an asterisk (*): * < 0.05 = p-value less than 0.05; ** < 0.01 = p-value less than 0.01; *** < 0.001 = p-value less than 0.001.
FIGURE 3LEfSe histograms of differential features in head and neck cancer patients. (A) Grp-All BPST. (B) Grp-noAB BPST. Linear discriminant analysis Effect Size (LEfSe) was performed to determine distinct microbiome features in oral samples [stimulated saliva (S) samples and swabs of buccal mucosa (B), supragingival plaque (P), and tongue (T)] of the following: (A) Grp-All patient cohort (N = 23) for the head and neck cancer (HNC) HPV-positive (HPV+; N = 16) vs. HPV-negative (HPV–; N = 7) comparisons. (B) Grp-noAB patient cohort (N = 15) for HNC HPV+ (N = 12) vs. HPV– (N = 3) that did not receive antibiotics within 2 weeks of sampling. Horizontal histograms depict the discriminant features, i.e., bacterial species, for Grp-All and Grp-noAB potential biomarkers for HPV+ (red) and HPV– (blue). Mann–Whitney U-tests were used to determine significance of HPV+ distinctive species. Level of significance is depicted by an asterisk (*): *p < 0.05; **p < 0.01; ***p < 0.001.
FIGURE 4HNC HPV+ vs. HNC HPV– CombiROC analysis using RA and log(RA + 1) transformed abundance data. (A) CombiROC analysis for biomarkers with AUC > 0.75 on RA data. (B) CombiROC analysis for biomarkers with AUC > 0.75 on log(RA + 1) data. Significant (α = 0.05) CombiROC program-generated receiver operator characteristic (ROC) curves for (A) RA data and (B) log(RA + 1) transformed abundance data of candidate microbial biomarkers (AUC > 0.75; n = 10 bacterial species) identified via MedCalc Software for Grp-All HPV+ vs. HPV– group are shown. (A) ROC curves, violin plots, and descriptive statistic summary table for the best two combinations from 10 potential markers using the RA are shown. “Combo XXII” consists of a combination of the markers Ruminococcaceae sp075, Haemophilus parainfluenzae, Haemophilis pittmaniae, Leptotrichia sp212, and Leptotrichia sp417 (ROC curve blue line). “Combo XV” contains markers Ruminococcaceae sp075, H. pittmaniae, Leptotrichia sp212, and Leptotrichia sp417 (ROC curve black line). (B) ROC curves, violin plots, and descriptive statistic summary table for the best two combinations from 10 potential markers using the log(RA + 1) transformed data are shown. “Combo XLII” contains potential markers Gemella sanguinis, H. pittmaniae, Leptotrichia sp212, and Ruminococcaceae sp075 (ROC curve blue line). “Combo XXXVI” consists of species probes TM7 G1 sp352, H. pittmaniae, Leptotrichia sp221, Leptotrichia sp417, and Ruminococcaceae sp075 (ROC curve black line). Cut-off refers to the optimal value or the highest true positive rate that has the lowest false positive rate. FN, false negative; FP, false positive; TN, true negative; TP, true positive; AUC, area under the curve; SE, sensitivity; SP, specificity; ACC, accuracy; PPV, positive predictive value.
FIGURE 5MIND interaction network of Haemophilus and Leptotrichia spp. Microbial Interaction Network Database (MIND; http://www.microbialnet.org/mind_home.html) results, illustrating a network between Haemophilus spp. (left red circle) and Leptotrichia spp. (right red circle) by using MIND default options, are presented. Dark green circles depict genera that interact with Haemophilus spp./Leptotrichia spp., and light green circles depict species that interact with Haemophilus spp./Leptotrichia spp. The lines between Haemophilus spp. and Leptotrichia spp. show interactions in common with other genera and species. The different color lines depict the human tissue sites where interactions have been demonstrated in previous studies (MIND; http://www.microbialnet.org/mind_home.html).
LitSuggest positively classified articles (n = 15) involving HPV and the oral microbiome in HNC patients.
| Year | Author | Purpose of study | Findings | PMID |
| 2021 | Review the significance of biomarkers based on epigenetics and microbiome profile in the diagnosis of HPV-related OSCC. | 33521000 | ||
| 2021 | Knowledge and biomarkers in HNC-SCC. | HPV is a biomarker of HNC-SCC; | 33916646 | |
| 2021 |
| Characterize microbiome of human palatine tonsil crypts in patients with high-risk HPV-associated tonsil cancer compared to sleep apnea controls. | 34367729 | |
| 2021 |
| Characterize oral and gut microbiome of HPV+ OSCC patients before and after CRT. | 33750907 | |
| 2021 |
| Characterize microbiome in patients with HPV-associated early tonsil SCC compared to benign tonsil specimens. | 33905914 | |
| 2021 |
| Characterize HPV16 DNA prevalence and PD inflammation in older Japanese women. | 33456534 | |
| 2021 | Review recent findings of oral HPV infection in relation to periodontitis. | HPV localizes to inflammatory periodontal tissue, and periodontal pockets may act as a reservoir for HPV. Smoking is associated with HPV and periodontitis. Carcinogenic HPV and periodontitis may lead to OCC, but HPV E6/E7 has not been fully investigated in patients with periodontitis. Oral HPV prevalence may be associated with periodontitis. | 33728046 | |
| 2021 |
| Compare microbial composition, diversity, and specific bacterial phytotypes between HPV+ and HPV– oropharyngeal tumors using saliva, normal tissue, and tumor tissue. | 34278648 | |
| 2020 |
| Characterize tumor microenvironment of HPV-associated OSCC with RT +/– cisplatin-based chemotherapy using surface swab of tonsil, base of tongue, and buccal mucosa. | Decreased α-diversity over course of treatment. | 33367119 |
| 2019 |
| Explore deep-seated infected granulation tissue removed during periodontal flap surgery procedures for residential bacterial species between HPV+ and HPV– chronic periodontitis patients. | Deep-seated granulation tissues showed | 31111067 |
| 2018 |
| Characterize the oral microbiome fluctuation associated with OCC and OSCC compared to healthy controls using oral wash samples. | 30123780 | |
| 2018 |
| Investigate the association between HPV infection and microbiome composition in the placenta, uterine cervix, and mouth in women | 29955075 | |
| 2017 |
| Characterize microbial species in the saliva microbiome and tumor characteristics in HNC-SCC patients. | 29340028 | |
| 2017 |
| Compare oral salivary microbiome samples of patients with OCC and OSCC vs. healthy controls. | Shannon index found higher diversity in tumor patients but was not significant. Highest LEfSe LDA was from | 28725009 |
| 2016 |
| Compare saliva microbiome from HPV+ and HPV–, OCC, OSCC, and normal cavity epithelium. | 27259999 |
Using Python